Adderall-XR Versus Concerta For Cancer Treatment-Related Neurocognitive Sequelae And Depression In Pediatric Patients: A Randomized Phase II Study.

Trial Profile

Adderall-XR Versus Concerta For Cancer Treatment-Related Neurocognitive Sequelae And Depression In Pediatric Patients: A Randomized Phase II Study.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 21 May 2013

At a glance

  • Drugs Methylphenidate (Primary) ; Mixed amfetamine salts (Primary)
  • Indications Cognition disorders; Depression
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 11 Sep 2010 Actual end date (Jun 2006) added as reported by ClinicalTrials.gov.
    • 27 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top